Looking for our Business Solutions? Click here:CloudQuote APIsContact Us

InspireMD Inc. - Common Stock (NSPR)

1.3500
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 18th, 9:35 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close1.350
Open1.340
Bid1.330
Ask1.420
Day's Range1.320 - 1.390
52 Week Range1.280 - 2.932
Volume145,506
Market Cap57.20M
PE Ratio (TTM)-1.627
EPS (TTM)-0.8
Dividend & YieldN/A (N/A)
1 Month Average Volume49,863

Chart

About InspireMD Inc. - Common Stock (NSPR)

InspireMD Inc is a medical device company that specializes in developing innovative solutions for the treatment of cardiovascular diseases. Its primary focus is on providing advanced stent technologies that enhance the treatment of vascular conditions, primarily through its proprietary MGuard stent platform. This platform utilizes a unique design that incorporates a polymeric mesh to protect the vascular walls during and after procedures, aiming to improve patient outcomes and reduce complications. The company's commitment to research and development underpins its mission to offer groundbreaking products that address unmet medical needs in the field of interventional cardiology and vascular care. Read More

News & Press Releases

InspireMD Inc (NSPR) Q3 2025 Earnings Top Estimates, Fueled by Strong Sales Beatchartmill.com
InspireMD (NSPR) Q3 2025 results beat revenue estimates by 40%, driven by the successful U.S. launch of its CGuard Prime carotid stent system.
Via Chartmill · November 4, 2025
Earnings Scheduled For November 4, 2025benzinga.com
Via Benzinga · November 4, 2025
Earnings Scheduled For August 5, 2025benzinga.com
Via Benzinga · August 5, 2025
RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors
ALISO VIEJO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced the appointment of Raymond W. Cohen to its Board of Directors.
By RxSight, Inc. · Via GlobeNewswire · August 4, 2025
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · August 1, 2025
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · July 31, 2025
A Look Ahead: InspireMD's Earnings Forecastbenzinga.com
Via Benzinga · May 8, 2025
Earnings Scheduled For November 12, 2024benzinga.com
Via Benzinga · November 12, 2024
Preview: InspireMD's Earningsbenzinga.com
Via Benzinga · March 5, 2024
Unusual volume stocks are being observed in Wednesday's session.chartmill.com
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill · June 25, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 25, 2025
Why BlackBerry Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · June 25, 2025
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · June 24, 2025
Earnings Scheduled For November 6, 2023benzinga.com
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via Benzinga · November 6, 2023
InspireMD Earnings Previewbenzinga.com
Via Benzinga · November 3, 2023
InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimisticstocktwits.com
The company’s revenue increased marginally to $1.52 million, driven by the continued adoption of its CGuard technology in existing markets.
Via Stocktwits · May 9, 2025
Earnings Scheduled For May 9, 2025benzinga.com
Via Benzinga · May 9, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga.com
Via Benzinga · December 3, 2024
Earnings Scheduled For March 12, 2025benzinga.com
Via Benzinga · March 12, 2025
NSPR Stock Earnings: InspireMD Misses EPS, Misses Revenue for Q2 2024investorplace.com
NSPR stock results show that InspireMD missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 6, 2024
NSPR Stock Earnings: InspireMD Misses EPS, Beats Revenue for Q1 2024investorplace.com
NSPR stock results show that InspireMD missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 14, 2024
NSPR Stock Earnings: InspireMD Beats EPS, Beats Revenue for Q4 2023investorplace.com
NSPR stock results show that InspireMD beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 6, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · August 23, 2023
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · July 21, 2023
Earnings Scheduled For March 6, 2024benzinga.com
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.
Via Benzinga · March 6, 2024